Table 5.
Multivariable model of variables associated with receipt of two or more breast imaging exams in the 6–26 months after diagnosis among tested women (N = 731)
| OR | (95% CI) | P | |
|---|---|---|---|
| Recurrence score | 0.06 | ||
| Low or intermediate (ref) | |||
| High | 0.49 | (0.23–1.03) | |
| Age at diagnosis, years | 0.08 | ||
| 24–39 | 0.36 | (0.14–0.90) | |
| 40–49 | 1.18 | (0.72–1.92) | |
| 50–59 (ref) | |||
| 60–63 | 1.23 | (0.69–2.19) | |
| Stage | 0.48 | ||
| I | 1.22 | (0.70–2.12) | |
| II (ref) | |||
| Chemotherapy | 0.33 | ||
| Yes | |||
| No (ref) | 1.29 | (0.77–2.15) | |
| Histological grade | 0.84 | ||
| 1–2 (well/moderately differentiated) (ref) | |||
| 3 (poorly or not differentiated) | 1.06 | (0.58–1.95) | |
| Nodal involvement | 0.58 | ||
| N0 (ref) | |||
| N1mic/N1 | 1.27 | (0.54–2.99) | |
| Surgery type | <0.001 | ||
| Breast-conserving surgery | 3.75 | ||
| Unilateral mastectomy (ref) |
Nodal involvement: N0 no cancer in the lymph nodes; N1mic lymph node cancer that can only be seen under a microscope (<2 mm in size); N1 cancer at least 2 mm in size in at least one of three axillary lymph nodes